The Ultimate Guide To Xarelto Lawsuit

From EjWiki

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical firms, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably secure for use - and failure to accomplish so may possibly be grounds for compensation. Our lawyers are functioning hard to have these hurt by the drug the compensation they're entitled to.

Although bleeding is actually a common complication associated with anticoagulants, it has been alleged that Xarelto is much more dangerous than standard blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This signifies that, inside the occasion of an emergency, patients may be at danger for irreversible bleeding difficulties, such as life-threatening internal and gastrointestinal hemorrhaging.

Should you or perhaps a loved one suffered a significant bleeding event following taking Xarelto, you might have legal recourse. For a lot more info, get in touch with us today to have your case reviewed, free of charge of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in cases of death, funeral costs. Additionally, they're in search of punitive damages, which are usually awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
indicaֳ§ֳ£o do xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit this page for a lot more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.